Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure

1984 ◽  
Vol 54 (8) ◽  
pp. 1020-1024 ◽  
Author(s):  
Arshed A. Quyyumi ◽  
Donald Wagstaff ◽  
Tom R. Evans
1996 ◽  
Vol 1 (3) ◽  
pp. 259-264
Author(s):  
Peter Ott ◽  
Frank I. Marcus

It is now well established that digoxin is an effective drug for the treatment of heart failure. Since treatment with angiotensin-converting enzyme (ACE) inhibitors reduces mortality in congestive heart failure, digoxin should be added to ACE inhibitors in patients with moderate or severe heart failure. The beneficial effects of digoxin may be due, in part, to its well-documented sympathoinhibitory effects that can avert the adverse effects of long-term excessive sympathetic adrenergic stimulation in heart failure.


1981 ◽  
Vol 102 (3) ◽  
pp. 555-563 ◽  
Author(s):  
Najam A. Awan ◽  
Kathleen Needham ◽  
Mark K. Evenson ◽  
John Hermanovich ◽  
James A. Joye ◽  
...  

1985 ◽  
Vol 55 (8) ◽  
pp. 1037-1042 ◽  
Author(s):  
Jadwiga Szlachcic ◽  
Barry M. Masse ◽  
Barry L. Kramer ◽  
Nina Topic ◽  
Julio Tubau

1989 ◽  
Vol 14 ◽  
pp. S93-S103 ◽  
Author(s):  
E. Rolandi ◽  
F. Sabino ◽  
V. Cantoni ◽  
P. Ghirardi ◽  
G. V. Marchetti ◽  
...  

1984 ◽  
Vol 53 (9) ◽  
pp. 1316-1320 ◽  
Author(s):  
Barry M. Massie ◽  
Barry L. Kramer ◽  
Nina Topic

Sign in / Sign up

Export Citation Format

Share Document